Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Role of microglia in methamphetamine-induced neurotoxicity.

Xu E, Liu J, Liu H, Wang X, Xiong H.

Int J Physiol Pathophysiol Pharmacol. 2017 Jun 15;9(3):84-100. eCollection 2017. Review.

2.

Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current.

Liu J, Xu E, Tu G, Liu H, Luo J, Xiong H.

Mol Cell Neurosci. 2017 Jul;82:167-175. doi: 10.1016/j.mcn.2017.05.009. Epub 2017 May 25.

PMID:
28552341
3.

TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation.

Shan M, Lin S, Li S, Du Y, Zhao H, Hong H, Yang M, Yang X, Wu Y, Ren L, Peng J, Sun J, Zhou H, Su B.

Front Cell Neurosci. 2017 Feb 22;11:35. doi: 10.3389/fncel.2017.00035. eCollection 2017.

4.

Mir143-BBC3 cascade reduces microglial survival via interplay between apoptosis and autophagy: Implications for methamphetamine-mediated neurotoxicity.

Zhang Y, Shen K, Bai Y, Lv X, Huang R, Zhang W, Chao J, Nguyen LK, Hua J, Gan G, Hu G, Yao H.

Autophagy. 2016 Sep;12(9):1538-59. doi: 10.1080/15548627.2016.1191723. Epub 2016 Jul 27.

5.

Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

Thanos PK, Kim R, Delis F, Ananth M, Chachati G, Rocco MJ, Masad I, Muniz JA, Grant SC, Gold MS, Cadet JL, Volkow ND.

PLoS One. 2016 Jun 8;11(6):e0155457. doi: 10.1371/journal.pone.0155457. eCollection 2016. Erratum in: PLoS One. 2017 Feb 8;12 (2):e0172080.

6.

Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets.

Najera JA, Bustamante EA, Bortell N, Morsey B, Fox HS, Ravasi T, Marcondes MC.

BMC Immunol. 2016 Apr 23;17(1):7. doi: 10.1186/s12865-016-0145-0.

7.

Sex differences in impulsivity and brain morphometry in methamphetamine users.

Kogachi S, Chang L, Alicata D, Cunningham E, Ernst T.

Brain Struct Funct. 2017 Jan;222(1):215-227. doi: 10.1007/s00429-016-1212-2. Epub 2016 Apr 19.

PMID:
27095357
8.

Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.

Worley MJ, Heinzerling KG, Roche DJ, Shoptaw S.

Drug Alcohol Depend. 2016 May 1;162:245-50. doi: 10.1016/j.drugalcdep.2016.02.036. Epub 2016 Mar 3.

9.

Vascular-directed responses of microglia produced by methamphetamine exposure: indirect evidence that microglia are involved in vascular repair?

Bowyer JF, Sarkar S, Tranter KM, Hanig JP, Miller DB, O'Callaghan JP.

J Neuroinflammation. 2016 Mar 12;13(1):64. doi: 10.1186/s12974-016-0526-6.

10.

Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Krasnova IN, Justinova Z, Cadet JL.

Psychopharmacology (Berl). 2016 May;233(10):1945-62. doi: 10.1007/s00213-016-4235-8. Epub 2016 Feb 12. Review.

11.

Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.

McConnell SE, O'Banion MK, Cory-Slechta DA, Olschowka JA, Opanashuk LA.

Neurotoxicology. 2015 Sep;50:131-41. doi: 10.1016/j.neuro.2015.08.006. Epub 2015 Aug 15.

12.

Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology.

Yu S, Zhu L, Shen Q, Bai X, Di X.

Behav Neurol. 2015;2015:103969. doi: 10.1155/2015/103969. Epub 2015 Mar 12. Review.

13.

Methamphetamine effects on blood-brain barrier structure and function.

Northrop NA, Yamamoto BK.

Front Neurosci. 2015 Mar 4;9:69. doi: 10.3389/fnins.2015.00069. eCollection 2015. Review.

14.

Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity.

Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW.

ACS Chem Neurosci. 2015 May 20;6(5):790-9. doi: 10.1021/acschemneuro.5b00010. Epub 2015 Mar 9.

15.

Neuroimmune basis of methamphetamine toxicity.

Loftis JM, Janowsky A.

Int Rev Neurobiol. 2014;118:165-97. doi: 10.1016/B978-0-12-801284-0.00007-5. Review.

16.

Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance.

Jan RK, Lin JC, Miles SW, Kydd RR, Russell BR.

Brain Sci. 2012 Oct 30;2(4):553-72. doi: 10.3390/brainsci2040553.

17.

Functional and structural brain changes associated with methamphetamine abuse.

Jan RK, Kydd RR, Russell BR.

Brain Sci. 2012 Oct 1;2(4):434-82. doi: 10.3390/brainsci2040434.

18.

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.

Castelli MP, Madeddu C, Casti A, Casu A, Casti P, Scherma M, Fattore L, Fadda P, Ennas MG.

PLoS One. 2014 May 20;9(5):e98079. doi: 10.1371/journal.pone.0098079. eCollection 2014.

19.

Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.

Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R.

Neuropsychopharmacology. 2014 Apr;39(5):1066-80. doi: 10.1038/npp.2013.307. Epub 2013 Oct 30.

20.

Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration?

Friend DM, Fricks-Gleason AN, Keefe KA.

Neurotox Res. 2014 Feb;25(2):153-60. doi: 10.1007/s12640-013-9415-2. Epub 2013 Aug 6. Review.

Supplemental Content

Support Center